Neurogene Inc.

Historical 13F Holders

Symbol
NGNE
CUSIP
64135M105
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 64135M105 since 12/18/2024, largest first.

Filer % of Class Filed
Prudential Financial Inc 13G 11.2% 10/7/2026
Event 9/30/2026
Jennison Associates LLC 13G 11.1% 10/6/2026
Event 9/30/2026
Redmile Group, LLC 13G/A
9.9% 8/14/2026
Event 6/30/2026
EcoR1 Capital, LLC 13G/A
9.9% 11/14/2025
Event 9/30/2025
Samsara BioCapital, L.P. 13G/A
9.7% 11/16/2026
Event 9/30/2026
RTW Investments, LP 13G/A
9.3% 11/16/2026
Event 9/30/2026
Casdin Capital, LLC 13G/A
8.7% 2/14/2025
Event 12/31/2024
BlackRock, Inc. 13G/A 6.8% 4/23/2025
Event 3/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (7)
Baker Bros. Advisors LP 13G/A
4.99% 11/16/2026
Event 9/30/2026
Trails Edge Capital Partners, LP 13G/A
4.5% 8/14/2026
Event 6/30/2026
FMR LLC 13G/A
3.1% 5/12/2025
Event 3/31/2025
Commodore Capital LP 13G/A
3.0% 8/14/2025
Event 6/30/2025
Great Point Partners, LLC 13G/A
3.0% 2/14/2025
Event 12/31/2024
Balyasny Asset Management L.P. 13G/A
1.5% 11/16/2026
Event 9/30/2026
Janus Henderson Group PLC 13G/A 0% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 133 24.0 M $667M
2026 Q2 112 17.3 M $544M
2026 Q1 98 17.0 M $342M
2025 Q4 94 16.5 M $340M
2025 Q3 89 15.3 M $265M
2025 Q2 85 15.4 M $230M
2025 Q1 88 16.5 M $193M
2024 Q4 92 16.1 M $368M
2024 Q3 87 13.8 M $581M
2024 Q2 67 13.3 M $483M
2024 Q1 61 12.1 M $617M
2023 Q4 36 9.23 M $179M